Manufacturer record
Acme Generics Private Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Acme Generics Private Limited (Himachal Pradesh) were declared Not of Standard Quality between March 2021 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Acme Generics Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium Tables IP 50mg | G25RDA025Mfg 2025-05 · Exp 2027-04 | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Diclofenac Sodium Tablets IP 50mg(Reactin 50) | G25RDA016Mfg 2025-03 · Exp 2027-02 | Sample fail the test DissolutionDissolution | DTL, Thiruvananthapuram, KeralaState lab | Oct 2025 |
| ORLICA (Orlistat Capsules U.S.P. 120 mg) | G22OEB001Mfg 2022-06 · Exp 2024-05 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2023 |
| CHYMOCIP (Trypsin & Chymotrypsin Tablets) | G19CHP004Mfg 2019-06 · Exp 2022-05 | Assay of Trypsin and ChymotrypsinAssay | CDL KolkataCDSCO lab | Mar 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.